Akèy › Enfeksyon Viral
Etid klinik pou Enfeksyon Viral ap rekrite nan Etazini
31 etid pou Enfeksyon Viral ap rekrite patisipan nan sit atravè Etazini.
Vil ki gen plis etid
- Washington, DC12 etid
- Houston, TX6 etid
- Boston, MA6 etid
- Baltimore, MD5 etid
- Hialeah, FL5 etid
- Columbus, OH4 etid
- Atlanta, GA4 etid
- Dallas, TX4 etid
- Cincinnati, OH4 etid
- St. Louis, MO3 etid
- San Francisco, CA3 etid
- Boise, ID3 etid
- Omaha, NE3 etid
- Worcester, MA3 etid
- Tampa, FL3 etid
- Miami, FL3 etid
- Los Angeles, CA3 etid
- Durham, NC3 etid
- Salt Lake City, UT3 etid
- New York City, NY3 etid
Pa eta
- Alabama3 etid
- Colorado3 etid
- Distrik Columbia5 etid
- Florid6 etid
- Georgia5 etid
- Idaho3 etid
- Illinois3 etid
- Kalifòni11 etid
- Kentucky3 etid
- Lwizyàn3 etid
- Maryland14 etid
- Massachusetts6 etid
- Michigan3 etid
- Missouri4 etid
- Nebraska3 etid
- New York6 etid
- North Carolina5 etid
- Ohio9 etid
- Pennsylvania5 etid
- South Carolina3 etid
- Texas9 etid
- Utah4 etid
- Virginia4 etid
Etid ki fèk mete ajou
Tèks ofisyèl etid la (Anglè)
Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT05624450A Study of S-337395 in Symptomatic Nonhospitalized Adults With Respiratory Syncytial Virus (RSV) Who Are at High Risk of Progression to Severe Disease
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 29, 2026 · NCT07214571Specimen Collections From Participants With HIV Infection, KSHV Infection, Viral-Related Pre-malignant Lesions and Cancer
Ap rekriteEtid obsèvasyon
Laj 18 a 120 · Tout sèks · Mizajou Sep 28, 2026 · NCT00006518The Natural History of Severe Viral Infections and Characterization of Immune Defects in Patients Without Known Immunocompromise
Ap rekriteEtid obsèvasyon
Laj 2 a 100 · Tout sèks · Mizajou Sep 28, 2026 · NCT01011712A Study of COVID-19 Vaccine(s) in Children and Adults
Ap rekriteFaz 3Volontè an sante akeyi
Laj 5 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07798648A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease
Ap rekriteFaz 3
Laj 12 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT06679140A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT07013474Phase 1 Challenge Study Using rDEN2delta30-7169 to Evaluate Host-Pathogen Interactions in Primary, Homotypic, and Heterotypic Dengue Virus Infection
Ap rekriteFaz 1Volontè an sante akeyi
Laj 18 a 50 · Tout sèks · Mizajou Sep 25, 2026 · NCT07706686Study of AHB-137 in Chronic Hepatitis B (CHB) Participants in North America and Europe Regions
Ap rekriteFaz 2
Laj 18 a 65 · Tout sèks · Mizajou Sep 24, 2026 · NCT07654283A Clinical Study to Investigate the Safety and Immunogenicity of rVSV∆G-SUDV-GP, a Sudan Virus (SUDV) Vaccine for the Prevention of SUDV Disease in Adults in Good General Health
Ap rekriteFaz 1Volontè an sante akeyi
Laj 18 a 50 · Tout sèks · Mizajou Sep 21, 2026 · NCT07565090Evaluating the Dose, Safety, Tolerability, and Immunogenicity of Mosaic Hexavalent Influenza Vaccine VRCFLUMOS0116-00-VP (FluMos-v2) With and Without ALFQ Adjuvant in Healthy Adults
Ap rekriteFaz 1Volontè an sante akeyi
Laj 18 a 50 · Tout sèks · Mizajou Sep 15, 2026 · NCT06863142Viral Infections in Healthy and Immunocompromised Hosts
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
6 Months – 120 Years · Tout sèks · Mizajou Sep 14, 2026 · NCT01306084Acute Infection in Mitochondrial Disease: Metabolism, Infection and Immunity
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
2 Months – 115 Years · Tout sèks · Mizajou Sep 10, 2026 · NCT04419870HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
Ap rekriteFaz 1
36 Months – 22 Years · Tout sèks · Mizajou Sep 4, 2026 · NCT03911388Trial of Scheduled Versus Treatment Administration of Donor-Derived Viral Specific T-cells for Viral Infections After Stem Cell Transplant
Ap rekriteFaz 2
Tout laj · Tout sèks · Mizajou Sep 4, 2026 · NCT04230356Donor-Derived Viral Specific T-cells (VSTs)
Ap rekriteFaz 1/2
4 Weeks · Tout sèks · Mizajou Sep 4, 2026 · NCT02048332Third Party Viral Specific T-cells (VSTs)
Ap rekriteFaz 2
2 Days · Tout sèks · Mizajou Sep 4, 2026 · NCT02532452A Phase 1/2A, Randomized Study of a T Follicular Helper (TFH)-Targeting Genetic Vaccine Strategy Designed to Induce Broad, Durable Immune Responses
Ap rekriteFaz 1/2Volontè an sante akeyi
Laj 40 a 64 · Tout sèks · Mizajou Aug 18, 2026 · NCT06810934A Study to Learn About a COVID-19 Vaccine in Healthy Adults 18 Through 64 Years of Age
Ap rekriteFaz 4Volontè an sante akeyi
Laj 18 a 64 · Tout sèks · Mizajou Aug 7, 2026 · NCT07730450Genetic Studies of Chronic Active Epstein-Barr Disease
Ap rekriteEtid obsèvasyon
Laj 1 a 120 · Tout sèks · Mizajou Jul 28, 2026 · NCT00032513TETRAVI Multivirus CTL for Treatment of EBV, CMV, Adenovirus, and BK Infections Post Allogeneic SCT.
Ap rekriteFaz 1
Tout laj · Tout sèks · Mizajou Jun 11, 2026 · NCT04013802Treatment of Refractory BK Infections With Related Donor BK Specific Cytotoxic T-cells (CTLs)
Ap rekriteFaz 1/2
1 Month – 79 Years · Tout sèks · Mizajou Apr 15, 2026 · NCT04197596A Study to Investigate the Immunogenicity and Safety of mRNA COVID-19 Variant-containing Vaccine Formulations
Ap rekriteFaz 4Volontè an sante akeyi
6 Months · Tout sèks · Mizajou Mar 27, 2026 · NCT06585241Microbial Cell-free Metagenomic Sequencing for Suspected Infections in Adult Immunocompromised Outpatients
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Jan 30, 2026 · NCT07110636Adoptive T Lymphocyte Administration for Chronic Norovirus Treatment in Immunocompromised Hosts
Ap rekriteFaz 1
3 Months – 80 Years · Tout sèks · Mizajou Jan 26, 2026 · NCT04691622Sous ClinicalTrials.gov, done yo ranmase Oct 4, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.